Research programme: COVID-2019 infections therapies - Anna Biosciences
Latest Information Update: 07 Jul 2021
At a glance
- Originator Anna Biosciences
- Class Antivirals
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research COVID 2019 infections